REVB
Revelation Biosciences Inc
NASDAQ: REVB · HEALTHCARE · BIOTECHNOLOGY
$1.12
-0.88% today
Updated 2026-05-01
Market cap
$4.32M
P/E ratio
—
P/S ratio
2.88x
EPS (TTM)
$-23.95
Dividend yield
—
52W range
$1 – $40
Volume
0.1M
Revelation Biosciences Inc (REVB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | $11.60M | $11.60M | $24.25M | $32.58M | $41.09M | $-215074.00 | $-11.09M | $-11.22M | $-7.29M | $-18.32M | $-8.27M |
| Capital expenditures | $0.00 | $582000.00 | $582000.00 | $804000.00 | $861000.00 | $526000.00 | $4.00 | $131963.00 | $4.00 | $4.00 | $19171.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $43848.00 | $470878.00 | $301116.00 | $155721.00 | $168850.00 | $595368.00 |
| Free cash flow | — | $11.02M | $11.02M | $23.44M | $31.72M | $40.56M | $-215078.00 | $-11.22M | $-11.22M | $-7.29M | $-18.34M | $-8.27M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | $7.65M | — | — | $5.95B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |